Guest guest Posted January 9, 2011 Report Share Posted January 9, 2011 Vasoactive intestinal peptide loss leads to impaired CNS parenchymal T-cell infiltration and resistance to experimental autoimmune encephalomyelitis http://www.pnas.org/content/107/45/19555.abstract Cutting Edge: Vasoactive Intestinal Peptide (VIP) Induces Differentiation of Th17 Cells with a Distinctive Cytokine Profile http://www.jimmunol.org/content/180/5/2772.abstract Altered expression of vasoactive intestinal peptide receptors in T lymphocytes and aberrant Th1 immunity in multiple sclerosis http://intimm.oxfordjournals.org/content/18/12/1691.full.pdf Vasoactive intestinal peptide-mediated Th17 differentiation: an expanding spectrum of vasoactive intestinal peptide effects in immunity and autoimmunity. http://www.ncbi.nlm.nih.gov/pubmed/19076367 Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.